British Journal of Pharmacology · 2007 · 72 citations · 21 references
Life SciencesImmunologyPharmacologyApoptosisCell SignalingInflammationAnti-inflammatory PharmacologyApoptosis ModulationApoptotic SignalingInflammation PharmacologyInflammatory SignalingLiposome-based DeliveryApoptotic Cell Clearance SignalingApoptotic ClearanceIn Vivo DeliveryIn Vivo StudiesLiposomesPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated ReceptorsPhosphatidylserine Receptors
BACKGROUND AND PURPOSE: Recently, there has been much attention paid to understanding the molecular mechanisms underlying apoptosis and the functional consequences of apoptotic body clearance by phagocytes. In an attempt to investigate this latter aspect, the present study evaluated the anti-inflammatory effects of in vivo administration of phosphatidylserine (PS) liposomes, a well-characterised membrane component expressed during apoptosis. The participation of peroxisome proliferator-activated receptors (PPARs) in PS-mediated effects was also investigated. EXPERIMENTAL APPROACH: The anti-inflammatory effect of PS liposomes on the delayed phase of carrageenan mouse paw oedema was studied. PS liposomes were injected at different doses and times, after carrageenan. Hind paws were collected for evaluation of interleukin-1beta (IL-1beta) levels, myeloperoxidase (MPO) and N-acetyl-glucosaminidase (NAG) activities and Evans blue dye leakage. Participation of PPAR pathways was explored by using PPAR antagonists (BADGE and GW9662). KEY RESULTS: Administration of PS, but not phosphatidylcholine (PC), liposomes (20-200 mg kg(-1), i.p., 8 h after carrageenan) reduced the paw oedema in a dose-dependent manner. PS liposomes were effective even when administered 24 and 48 h after carrageenan, a time at which indomethacin (1 mg kg(-1), i.p.) had no significant effects. Carrageenan-induced Evans blue leakage and IL-1beta production was decreased in PS-treated paws. The PPAR antagonists (BADGE and GW9662) partially prevented the anti-inflammatory effects of PS administration. CONCLUSIONS AND IMPLICATIONS: PS liposomes have anti-inflammatory effects in vivo that are at least partly dependent on PPAR activation. Therapeutic strategies mimicking apoptosis may be useful for the treatment of inflammatory disorders.
21
Valerie A. Fadok, Donna L. Bratton, Anatole Konowal et al. · Journal of Clinical Investigation · 1998 · 3.1K citations · Full text
Inducible cyclooxygenase may have anti-inflammatory properties
Derek W. Gilroy, Paul Colville‐Nash, Dean Willis et al. · Nature Medicine · 1999 · 1.2K citations
Valerie A. Fadok, Aimee de Cathelineau, David L. Daleke et al. · Journal of Biological Chemistry · 2001 · 637 citations · Full text